Cardiac autonomic neuropathy: a progressive consequence of chronic low-grade inflammation in type 2 diabetes and related metabolic disorders
Cardiac autonomic neuropathy (CAN) is one of the earliest complications of type 2 diabetes
(T2D), presenting a silent cause of cardiovascular morbidity and mortality. Recent research …
(T2D), presenting a silent cause of cardiovascular morbidity and mortality. Recent research …
Beat-to-beat blood pressure variability: an early predictor of disease and cardiovascular risk
Blood pressure (BP) varies on the long, short and very-short term. Owing to the hidden
physiological and pathological information present in BP time-series, increasing interest has …
physiological and pathological information present in BP time-series, increasing interest has …
Hemodynamic responses to handgrip and metaboreflex activation are exaggerated in individuals with metabolic syndrome independent of resting blood pressure …
J Stavres, RA Aultman, CF Brandner… - Frontiers in …, 2023 - frontiersin.org
Introduction: Prior studies report conflicting evidence regarding exercise pressor and
metaboreflex responses in individuals with metabolic syndrome (MetS). Purpose: To test the …
metaboreflex responses in individuals with metabolic syndrome (MetS). Purpose: To test the …
Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: Role of anti-diabetic drugs
Diabetic nephropathy is a major health challenge with considerable economic burden and
significant impact on patients' quality of life. Despite recent advances in diabetic patient care …
significant impact on patients' quality of life. Despite recent advances in diabetic patient care …
Modulatory effect of intermittent fasting on adipose tissue inflammation: amelioration of cardiovascular dysfunction in early metabolic impairment
Cardiometabolic syndrome (CMS) is a cluster of maladaptive cardiovascular, renal,
thrombotic, inflammatory, and metabolic disorders. It confers a high risk of cardiovascular …
thrombotic, inflammatory, and metabolic disorders. It confers a high risk of cardiovascular …
Phosphorus supplementation mitigates perivascular adipose inflammation–induced cardiovascular consequences in early metabolic impairment
Background The complexity of the interaction between metabolic dysfunction and
cardiovascular complications has long been recognized to extend beyond simple …
cardiovascular complications has long been recognized to extend beyond simple …
The pleiotropic effects of antithrombotic drugs in the metabolic–cardiovascular–neurodegenerative disease continuum: Impact beyond reduced clotting
Antithrombotic drugs are widely used for primary and secondary prevention, as well as
treatment of many cardiovascular disorders. Over the past few decades, major advances in …
treatment of many cardiovascular disorders. Over the past few decades, major advances in …
Spontaneous baroreflex sensitivity is attenuated in male UCD-type 2 diabetes mellitus rats: A link between metabolic and autonomic dysfunction
Patients with type 2 diabetes mellitus (T2DM) have impaired arterial baroreflex function,
which may be linked to the co-existence of obesity. However, the role of obesity and its …
which may be linked to the co-existence of obesity. However, the role of obesity and its …
High fat diet exacerbates long-term metabolic, neuropathological, and behavioral derangements in an experimental mouse model of traumatic brain injury
Aims Traumatic brain injury (TBI) constitutes a serious public health concern. Although TBI
targets the brain, it can exert several systemic effects which can worsen the complications …
targets the brain, it can exert several systemic effects which can worsen the complications …
Depot-specific adipose tissue modulation by SGLT2 inhibitors and GLP1 agonists mediates their cardioprotective effects in metabolic disease
Abstract Sodium-glucose transporter-2 inhibitors (SGLT-2i) and glucagon-like peptide 1
(GLP-1) receptor agonists are newer antidiabetic drug classes, which were recently shown …
(GLP-1) receptor agonists are newer antidiabetic drug classes, which were recently shown …